SECTION I: USE OF THE CLINICAL PRACTICE GUIDELINE
This Clinical Practice Guideline document is based upon the best information available
as of February 2011. It is designed to provide information and assist decision-making.
It is not intended to define a standard of care, and should not be construed as one,
nor should it be interpreted as prescribing an exclusive course of management. Variations
in practice will inevitably and appropriately occur when clinicians take into account
the needs of individual patients, available resources, and limitations unique to an
institution or type of practice. Every health-care professional making use of these
recommendations is responsible for evaluating the appropriateness of applying them
in the setting of any particular clinical situation. The recommendations for research
contained within this document are general and do not imply a specific protocol.
SECTION II: DISCLOSURE
Kidney Disease: Improving Global Outcomes (KDIGO) makes every effort to avoid any
actual or reasonably perceived conflicts of interest that may arise as a result of
an outside relationship or a personal, professional, or business interest of a member
of the Work Group. All members of the Work Group are required to complete, sign, and
submit a disclosure and attestation form showing all such relationships that might
be perceived or actual conflicts of interest. This document is updated annually and
information is adjusted accordingly. All reported information is published in its
entirety at the end of this document in the Work Group members' Biographical and Disclosure
Information section, and is kept on file at the National Kidney Foundation (NKF),
Managing Agent for KDIGO.